Stocks to Watch:

Cramer: Celgene Is a Buy as Biotech Deals Heat-up

TheStreet.com Videos 1:34 mins

Jim Cramer looks at the latest biotech deals as Cubist acquires Trius amid changes among Biotech companies.

View Comments (0)